Arterial hypoxia Withdrawn Phase 1 Trials for Ketorolac (DB00465)

Also known as: Hypoxia / Hypoxic

IndicationStatusPhase
DBCOND0023666 (Arterial hypoxia)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03066115Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow RegulationBasic Science